Smoking Cessation and Menstrual Cycle Phase

Tobacco use is a risk factor for at least 20 types of cancer and remains the leading preventable cause of cancer in Canada. Smoking cessation is an important cancer prevention strategy for the close to 2 million Canadian women who currently smoke. However, findings from controlled trials and real-world clinical settings indicate that women have greater difficulty achieving abstinence following a quit attempt than men. There is some evidence that hormonal levels and fluctuations throughout the menstrual cycle (MC) may contribute to the greater difficulty women experience when trying to quit smo

Trial Details

NCT ID
NCT05515354
Phase
PHASE4
Sponsor
Centre for Addiction and Mental Health
Status
RECRUITING
Cancer Type
Ovarian Cancer
Interventions
  • Timing of nicotine replacement therapy start date
  • Nicotine Replacement Therapy Agent
Locations (sample)
  • Toronto, Ontario, Canada|43.70643,-79.39864

Key Eligibility Criteria

  • Must provide informed consent following the CAMH REDCap e-consent framework and procedures;
  • Stated willingness to comply with all study procedures;
  • Naturally cycling individuals with regular MCs (defined as length ranging 21 to 35 days over past 6 months);
  • Daily smoker of ≥5 cigarettes per day (CPD) over past 6 months;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Ovarian Cancer Trials on Trialify →